RNU6-751P

Across TCGA pan-cancer cohorts, RNU6-751P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-751P data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RNU6-751P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-751P expression acts as an unfavorable survival marker.

CESC, ESCA, and LIHC are the cancer types where RNU6-751P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.167	0.798	<.001	90	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	63	view →
LIHC	OS	Tertile	All	0.061	0.783	<.001	36	view →
PAAD	OS	Tertile	All	0.138	0.590	<.001	27	view →
TGCT	DFS	Tertile	All	0.706	0.875	.020	12	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-751P–CESC (OS)

Open the CESC breakdown →